21![Cabergoline 1 Health Canada approved products : DIN[removed] Cabergoline 1 Health Canada approved products : DIN[removed]](https://www.pdfsearch.io/img/39664393ed100356b9bbd7d0a46dfb5b.jpg) | Add to Reading ListSource URL: medsask.usask.caLanguage: English - Date: 2014-06-26 20:29:50
|
---|
22![PRESCRIBING INFORMATION COMPAZINE® brand of prochlorperazine antiemetic antipsychotic tranquilizer DESCRIPTION PRESCRIBING INFORMATION COMPAZINE® brand of prochlorperazine antiemetic antipsychotic tranquilizer DESCRIPTION](https://www.pdfsearch.io/img/8c3b931bb87d4a1a9a82cce04849f4bb.jpg) | Add to Reading ListSource URL: www.reyessyndrome.orgLanguage: English - Date: 2008-12-17 11:24:01
|
---|
23![THORAZINE® brand of chlorpromazine antipsychotic• tranquilizer • antiemetic DESCRIPTION Thorazine (chlorpromazine) is[removed]dimethylaminopropyl)-2-chlorphenothiazine, a dimethylamine derivative of THORAZINE® brand of chlorpromazine antipsychotic• tranquilizer • antiemetic DESCRIPTION Thorazine (chlorpromazine) is[removed]dimethylaminopropyl)-2-chlorphenothiazine, a dimethylamine derivative of](https://www.pdfsearch.io/img/87d3e2725009c521a1b105747943fc0c.jpg) | Add to Reading ListSource URL: www.reyessyndrome.orgLanguage: English - Date: 2008-12-17 11:23:45
|
---|
24![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OXYTROL® safely and effectively. See full prescribing information for OXYTROL. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OXYTROL® safely and effectively. See full prescribing information for OXYTROL.](https://www.pdfsearch.io/img/33ef5fecce302e86dd1c701841c79e2b.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-10-15 15:54:03
|
---|
25![Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Anexate Solution for Inj/Inf 500 micrograms/5ml Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Anexate Solution for Inj/Inf 500 micrograms/5ml](https://www.pdfsearch.io/img/82267ea51568cde46f8f2cff7e8e26fb.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2011-06-06 13:37:39
|
---|
26![1-06-b IE[removed]Amisulpride - Art.45 Public AR 1-06-b IE[removed]Amisulpride - Art.45 Public AR](https://www.pdfsearch.io/img/993f5ad5389fa73f4a172a759d01e793.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-01-08 03:55:38
|
---|
27![w STATE OF IO\WA IO\TA DENTAL BOARD TeRRy E. BnnNsrao, GovnRNoR w STATE OF IO\WA IO\TA DENTAL BOARD TeRRy E. BnnNsrao, GovnRNoR](https://www.pdfsearch.io/img/a68cbf87ef86870c8fca08e9abbb2cca.jpg) | Add to Reading ListSource URL: www.state.ia.usLanguage: English - Date: 2012-10-11 09:51:01
|
---|
28![To: From: Physicians, Nurses, and Other Health Care Providers in American Samoa Ron Kirschner, MD Medical Director, Nebraska Regional Poison Center To: From: Physicians, Nurses, and Other Health Care Providers in American Samoa Ron Kirschner, MD Medical Director, Nebraska Regional Poison Center](https://www.pdfsearch.io/img/e87fce835bf3b5e06e4a38babbb39f52.jpg) | Add to Reading ListSource URL: www.nebraskapoison.comLanguage: English - Date: 2013-06-03 09:06:24
|
---|
29![HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use FANAPT safely and effectively. See full prescribing information for HIGHLIGHTS OF PRESCRIBING INFORMATION • These highlights do not include all the information needed to use FANAPT safely and effectively. See full prescribing information for](https://www.pdfsearch.io/img/e6f7de2f1d73ccf577adeda3fb985af4.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-04-22 13:43:10
|
---|
30![Guidance for Industry: Clinical Lactation Studies – Study Design, Data Analysis, and Recommendations for Labeling Guidance for Industry: Clinical Lactation Studies – Study Design, Data Analysis, and Recommendations for Labeling](https://www.pdfsearch.io/img/83c5ad90a742e47655cb8c1463a84094.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|